- SUBSTITUENT-INCLUDING UREA COMPOUND
-
An object of the present invention is to provide a compound that has a specific chemical structure having an activation effect on SIRT6 and is useful as an active component for preventing and treating inflammatory diseases. The present invention relates to a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. (Each symbol in Formula (1) has the same definition as that described in the specification.)
- -
-
Paragraph 0777-0779
(2021/12/03)
-
- Preparation method of substituted benzoxazole derivative
-
The invention discloses a preparation method of a substituted benzoxazole derivative, i.e., (1-(5-methoxybenzo[d]oxazole-2-yl)piperidin-4-yl)methylamine. According to the preparation method, 2-amino-4-methoxyphenol is taken as a starting raw material, and a target product is obtained by carrying out ring closing, chlorination, nucleophilic substitution, ammonolysis and reduction. The compound is an important medical intermediate.
- -
-
Paragraph 0025; 0026
(2018/03/24)
-
- OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF
-
The invention relates to octahydropyrrolo [3, 4-c] pyrrole derivatives and uses thereof. Compounds and pharmaceutical compositions comprising the compounds provided herein are used for antagonizing orexin receptors. The invention also relates to processes for preparing the compounds and pharmaceutical compositions, and uses thereof in treating or preventing a disease related to orexin receptors.
- -
-
Paragraph 00205
(2017/07/04)
-
- Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors
-
Two scaffolds based on 5,6-fused heterocyclic backbones were designed and synthesized as Raf kinase inhibitors. The scaffolds were assessed for in vitro pan-Raf inhibition, activity in cell proliferation and target modulation assays, and pharmacokinetic p
- Ramurthy, Savithri,Aikawa, Mina,Amiri, Payman,Costales, Abran,Hashash, Ahmad,Jansen, Johanna M.,Lin, Song,Ma, Sylvia,Renhowe, Paul A.,Shafer, Cynthia M.,Subramanian, Sharadha,Sung, Leonard,Verhagen, Joelle
-
supporting information; experimental part
p. 3286 - 3289
(2011/06/24)
-
- Analgesic Compounds, Compositions, and Uses Thereof
-
The invention relates to compounds, compositions, and methods for diminishing pain in a subject in need thereof comprising administering the compounds and compositions herein described.
- -
-
Page/Page column 21
(2011/10/04)
-
- Regulatory molecules for the 5-HT3 receptor ion channel gating system
-
Substituted benzoxazole derivatives which possess a nitrogen-containing heterocycle at C2 are selective partial agonists of the 5-HT3 receptor. Alteration of substituents on the benzoxazole nucleus affords both agonist-like and antagonist-like compounds, and uniquely modifies the function of the 5-HT3 receptor ion channel gating system. SAR and corroborative computational docking study for these partial agonists successfully explained structure and function of the 5-HT3 receptor.
- Yoshida, Satoshi,Watanabe, Takashi,Sato, Yasuo
-
p. 3515 - 3523
(2008/02/07)
-
- CYANOISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF
-
The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure: Formula (I).
- -
-
Page/Page column 86
(2008/06/13)
-
- Substituted benzazoles and methods of their use as inhibitors of Raf kinase
-
New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
- -
-
-
- Facile rearrangements of alkynylamino heterocycles with noble metal cations
-
A number of 2-(alkynylamino)-substituted heterocycles have been synthesized. These heterocycles rearrange in the presence of silver(I) and gold(I) salts to give novel 2H-pyrimido[2,1-b]benzoxazoles, 2H-pyrimido[2,1-b]benzothiazoles, and a 2H-pyrimido[2,1-b]benzoselenazole. Two of the the 2H-pyrimido[2,1-b]benzoxazoles were isolated in good yield. The kinetics of the silver tetrafluoroborate-catalyzed rearrangements of selected (alkynylamino)benzoxazoles and benzothiazoles have been examined by 1H NMR in CD3CN. Factors affecting the electron densities of the triple bond and of the nitrogen atom in the heterocycle are important in influencing the rate of rearrangement.
- Lok, Roger,Leone, Ronald E.,Williams, Antony J.
-
p. 3289 - 3297
(2007/10/03)
-
- Benzoxazolamines and Benzothiazolamines: Potent, Enantioselective Inhibitors of Leukotriene Biosynthesis with a Novel Mechanism of Action
-
A series of benzoxazolamine and benzothiazolamine analogs that inhibit leukotriene (LT) biosynthesis are described.The initial lead, (S)-N-(benzothiazol-2-yl)phenylalanine ethyl ester (5a), was discovered in a screening program for inhibition of Ca-ionophore-A23187-induced LTB4 release in human polymorphonuclear leukocytes (IC50 0.23 μM).Through structural modification, it was determined that hydrophobic substituents in the 5-position and replacement of the phenyl ring of phenylalanine with a cyclohexyl group greatly enhance potency.Several ester bioisosteres that retain potency and enantiomeric selectivity are described.Lead optimization culminated in (S)-N--5-methyl-2-benzoxazolamine (43b), IC50 0.001 μM.The compounds described are not inhibitors of 5-lipoxygenase but, rather, act at the level of arachidonic acid release.
- Lazer, Edward S.,Miao, Clara K.,Wong, Hin-Chor,Sorcek, Ronald,Spero, Denice M.,et al.
-
p. 913 - 923
(2007/10/02)
-
- 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: Inhibitors of immune complex induced inflammation
-
3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives were evaluated in the dermal and pleural reverse passive Arthus reactions in the rat. In the pleural test these compounds were effective in reducing exudate volume and accumulation of white blood cells. This pattern of activity was similar to that of hydrocortisone and different from that of indomethacin. The structural requirements for inhibiting the Arthus reactions were studied by systematic chemical modification of 1. These structure-activity relationship studies revealed that nitrogen 1' of the hydrazino group is essential for activity and must be electron rich, whereas chemical modifications of other sites of 1 had only a modest effect on activity.
- Haviv,Ratajczyk,DeNet,Kerdesky,Walters,Schmidt,Holms,Young,Carter
-
p. 1719 - 1728
(2007/10/02)
-